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Background-—Thoracic periaortic adipose tissue (TAT) is associated with atherosclerosis and cardiovascular disease (CVD) risk
factors and may play a role in obesity-mediated vascular disease. We sought to determine the prevalence, distribution, and risk
factor correlates of high TAT.
Methods and Results-—Participants from the Framingham Heart Study (n=3246, 48% women, mean age 51.1 years) underwent
multidetector computed tomography; high TAT and visceral adipose tissue (VAT) were deﬁned on the basis of sex-speciﬁc 90th
percentiles in a healthy referent sample. The prevalence of high TAT was 38.1% in women and 35.7% in men. Among individuals
without high VAT, 10.1% had high TAT. After adjustment for age and VAT, both women and men with high TAT in the absence of
high VAT were older and had a higher prevalence of CVD (P<0.0001) compared with those without high TAT. In addition, men in this
group were more likely to be smokers (P=0.02), whereas women were more likely to have low high-density lipoprotein cholesterol
(P=0.005).
Conclusions-—Individuals in our community-based sample with high TAT in the absence of high VAT were characterized by an
adverse cardiometabolic proﬁle. This adipose tissue phenotype may identify a subset of individuals with distinct metabolic
characteristics. (J Am Heart Assoc. 2012;0:e004200 doi: 10.1161/JAHA.112.004200)
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O
besity is associated with cardiovascular morbidity and
mortality.
1 The mechanisms by which obesity might
contribute to vascular disease remain incompletely under-
stood. Body fat distribution may be a cardiovascular risk
factor even after accounting for generalized adiposity.
2 One
component of abnormal body fat deposition involves the
deposition of adipose tissue, so-called ectopic fat, around
organs and the vasculature.
3 Perivascular fat is one such
ectopic fat depot that has been postulated to have a local
pathogenic effect on blood vessels.
4–8 Thoracic periaortic fat
is a subtype of perivascular fat that can be quantiﬁed using
multidetector computed tomography (MDCT).
9
Thoracic periaortic fat (TAT) may be a novel risk marker for
cardiovascular disease.
10,11 We have previously shown that
TAT is associated with certain metabolic risk factors after
adjustment for body mass index (BMI) as well as abdominal
aortic and coronary calcium after adjustment for either BMI or
visceral adipose tissue (VAT).
11 However, the prevalence and
age distribution of TAT in a community-based sample has not
been described. In addition, given the known correlation
between TAT and VAT
11 and the known association of VAT
with cardiometabolic risk,
12 we sought to examine the relative
association of high TAT versus high VAT with cardiometabolic
risk by examining different patterns of thoracic periaortic and
visceral fat deposition in a cohort of middle-aged individuals
enrolled in the Framingham Heart Study.
Methods
In 1971, children of those in the original Framingham Heart
Study cohort and their spouses were enrolled in the
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ORIGINAL RESEARCHOffspring cohort. In 2002, individuals with at least 1 parent
in the Offspring cohort were enrolled in the Third-Generation
cohort. The study designs have been described previ-
ously.
13,14 The present study included participants from the
Offspring and Third-Generation cohorts who participated in
the MDCT substudy between 2002 and 2005 as previously
described.
12 Of the 3529 participants in the MDCT substudy,
3246 had interpretable values for TAT. Of the individuals
with interpretable TAT, 3228 had interpretable values for
VAT. For individual regressions, any individuals with data
missing the covariate of interest were excluded. The study
protocol was approved by the institutional review boards of
the Boston University Medical Center and Massachusetts
General Hospital. All subjects provided written informed
consent.
MDCT Scan Protocol and Adipose Tissue
Measurements
Participants underwent radiographic assessment of their
thorax and abdomen in the supine position using an
8-slice MDCT scanner (LightSpeed Ultra, General Electric,
Milwaukee, WI) as previously described.
9 The thoracic scan
was performed during an inspiratory breath hold with
prospective ECG triggering (with the center of acquisition
window at 70% of the R-R cycle to minimize cardiac motion).
The average scan time was 18 seconds (tube voltage of
120 kVp, tube current of 320 mA (<220 lbs) or 400 mA
(>220 lbs) with a gantry rotation time of 500 ms and a
temporal resolution of 330 ms. Thoracic and abdominal
MDCT images were reconstructed as 2.5- and 5-mm nonov-
erlapping slices, respectively.
TAT and VAT were assessed using a dedicated workstation
(Aquarius 3D, TeraRecon, San Mateo, CA). Fat volumes were
measured by a semiautomatic segmentation technique
requiring manual deﬁnition of tissue borders. Fat within an
area of interest was deﬁned by pixels with characteristic
Hounsﬁeld units (HU; window width 195 to 45 HU;
window center 120 HU). The area of interest for TAT was
deﬁned anteriorly by the area immediately surrounding the
thoracic aorta (deﬁned by a line drawn horizontally through
the esophagus, which connected to the left costovertebral
joint) and posteriorly by the right lateral border of the
vertebral body and the anterior edge of the vertebral body.
9
This resulted in a 6.75-cm column of fat (27 slices)
surrounding the thoracic aorta. VAT was quantiﬁed on
abdominal scans as previously described.
12 Brieﬂy, the reader
deﬁned the area of interest by tracing the abdominal muscular
wall and separating the subcutaneous from the visceral
abdominal fat depot. These areas of interest were summed
over the 25 abdominal slices. Intrareader and interreader
(assessed between 2 readers) reproducibility was excellent for
both TAT and VAT, with intraclass and interclass correlations
>0.98.
9,15 A visual representation of the methodology for
measuring TAT is presented in Figure 1.
Covariate Assessment
Covariates were measured at the seventh Framingham
Offspring examination (1998–2001) and the ﬁrst Third-
Generation examination (2002–2005). BMI was deﬁned as
weight (in kilograms) divided by the square of the height (in
meters). Waist circumference (WC) was measured at the level
of the umbilicus. Current smoking was deﬁned as smoking ≥1
cigarette per day in the past year. Alcohol use was assessed
by physician-administered questionnaires, and dichotomized
on the basis of consumption of ≥14 drinks per week (in men)
or ≥7 drinks per week (in women). A physical activity index
(PAI) score was calculated by summing the reported numbers
for each level of activity, weighted by their estimated
metabolic expenditure, as described previously.
16 The PAI
ranges from a minimum score of 24, indicating 24 hours of
AB
Figure 1. A, The region of interest drawn around the aorta using anatomic landmarks. Adipose tissue within this region of interest, deﬁned as
pixels with Hounsﬁeld units between 195 and 45, is considered periaortic fat. B, 3D reconstruction. Reproduced from Fox et al (10) with
permission from the publisher.
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Hsleeping, to a maximum score of 120, indicating 24 hours of
heavy physical activity. Serum triglycerides, total and high-
density lipoprotein cholesterol, and fasting plasma glucose
were measured on fasting morning samples. Fasting plasma
glucose ≥126 mg/dL or treatment with a hypoglycemic agent
or insulin was used to deﬁne diabetes mellitus. Hypertension
was deﬁned as a systolic blood pressure ≥140 mm Hg,
diastolic blood pressure ≥90 mm Hg or treatment with an
antihypertensive agent. Metabolic syndrome was deﬁned from
the modiﬁed Adult Treatment Panel criteria.
17 If periods had
stopped for >1 year, women were considered postmeno-
pausal. Cardiovascular disease included coronary heart
disease, stroke, intermittent claudication, and congestive
heart failure.
Statistical Analysis
To determine the prevalence of high TAT, a healthy referent
sample was created by hierarchical exclusion of participants
with the following covariates: BMI≥30 kg/m
2 (n=874), pres-
ence of hypertension (or use of antihypertensive medications;
n=562), triglycerides ≥150 mg/dL or lipid-lowering medica-
tion (n=424), low high-density lipoprotein (HDL) cholesterol
(<40 mg/dL in men and <50 mg/dL in women; n=193),
impaired fasting glucose, diabetes or use of hypoglycemic
medications (n=215); prevalent cardiovascular disease (CVD;
n=9); current tobacco smoking (n=118); BMI<18.5 kg/m
2
(n=12), and missing covariates (n=24), resulting in 499
women and 316 men. We deﬁned high TAT as a sex-speciﬁc
fat volume ≥90th percentile from the healthy referent sample.
Sex-speciﬁc TAT volumes <90th percentile from the healthy
referent sample were classiﬁed as normal. The 90th percen-
tile was chosen to ensure adequate sample size in the healthy
referent sample to provide statistically robust estimates for
the fat volume cutoff values. This method used to determine
the volume for high TAT was the same as that used for other
fat depots in the Framingham Heart Study.
18,19 High TAT, by
this deﬁnition, corresponded with volumes ≥10.2 cm
3 in
women and ≥19.0 cm
3 in men. Prevalence estimates of high
TAT were then determined in the overall sample (including
those individuals who had been excluded from the healthy
referent sample) and stratiﬁed by sex and the following age
categories: 35 to 44, 45 to 54, 55 to 64, 65 to 74, and 75 to
84 years.
To establish the risk factor proﬁles associated with
different patterns of TAT and VAT, we stratiﬁed our sample
into 4 mutually exclusive categories on the basis of TAT and
VAT volumes: (A) normal TAT and normal VAT, (B) high TAT but
normal VAT, (C) high VAT and normal TAT, and (D) high TAT
and high VAT. High VAT has been previously deﬁned as
≥1359 cm
3 in women and ≥2323 cm
3 in men. Given the
known correlation between TAT and VAT,
10 we examined
differences in risk factor levels between the discordant
categories (groups B versus C) using sex-speciﬁc age-adjusted
analyses of covariance (ANCOVAs) and logistic regressions.
GiventhathighVATisalreadyrecognizedasassociatedwithan
adverse cardiometabolic risk factor proﬁle, we also examined
differences in risk factors among individuals with normal VAT
thatwerediscordantforhighTAT(groupsAversusB).Forthese
analyses, we used sex-speciﬁc ANCOVAs and logistic regres-
sions adjusted for age as well as the volume of VAT. We also
adjusted for VAT given that individuals with high TAT and
normal VAT tended to have higher absolute volumes of VAT
compared with those with normal TAT and normal VAT. We did
not adjust for height given the lack of documented association
between height and TAT (r=0.05, P=0.25 in women; r=0.01,
P=0.75 in men)
11 We tested for an age interaction across the 4
different categories of TAT/VAT. When age interactions were
signiﬁcant, we performed additional analyses stratiﬁed by
median age. Finally, we performed a sensitivity analysis
restricting our sample to the Third-Generation cohort in whom
risk factor assessment and MDCT scans were performed
during the same period.
SAS version 9.1 was used to perform all computations.
Two-sided P values <0.05 were considered signiﬁcant.
Because of the exploratory nature of this study, no adjust-
ments were made for multiple comparisons.
Results
Overall, 1558 women and 1688 men for a total sample of
3246 individuals were included in this analysis. For the overall
sample, the mean values for TAT in women and men were 9.9
and 17.5 cm
3, respectively. The characteristics of the sample
population are described in Table 1.
Distribution of Thoracic Periaortic Fat in the
Community
Sex- and age-speciﬁc TAT volumes are represented in Table 2.
TAT volumes increased with age into the eighth decade for
women and into the seventh decade for men for all
percentiles of fat.
Prevalence of High Thoracic Periaortic Fat
The overall and age-stratiﬁed prevalence of high TAT, deﬁned
as ≥90th percentile in the healthy referent sample, is reported
in Table 3. The overall prevalence for high TAT was 38.1% in
women and 35.7% in men and increased with age (P value for
linear trend <0.0001). As expected, the prevalence of high
TAT increased with increasing BMI and waist circumference
categories (Table 4).
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HCardiometabolic Risk Factor Proﬁles by Patterns
of Thoracic Periaortic Fat and Visceral Adipose
Tissue
Given the known high correlation between TAT and VAT
(r=0.75, P<0.001),
11 we divided individuals into 4 categories
on the basis of the presence or absence of high TAT and the
presence or absence of high VAT to better evaluate the
unique correlates of each fat depot. We then compared
cardiometabolic risk factors between individuals with high
TAT and normal VAT versus high VAT and normal TAT. In
addition, among individuals with normal VAT, we compared
cardiometabolic risk factors among individuals discordant for
high TAT.
In the overall sample, 16.4% of women and 18.8% of men
were discordant for high TAT and high VAT. Comparing
discordant groups, women with high TAT and normal VAT
compared with high VAT and normal TAT were older but
tended to have lower measures of clinical adiposity and better
cardiometabolic risk factor proﬁles after adjusting for age
(Table 5). In contrast, men with high TAT and normal VAT
compared with high VAT and normal TAT were older and had a
lower waist circumference, but otherwise the cardiometabolic
proﬁles were not signiﬁcantly different (Table 5).
Among individuals with normal VAT, high TAT compared
with normal TAT was associated with a more adverse
cardiometabolic proﬁle. Speciﬁcally, these individuals were
older and had a higher prevalence of the majority of
cardiometabolic risk factors, including a higher prevalence of
metabolic syndrome (Table 5). Findings were similar when we
also adjusted for BMI (data not shown). However, individuals
with high TAT and normal VAT also had a higher absolute
volume of VAT compared with individuals with normal TAT and
normal VAT. Given this difference in VAT volumes, our ﬁndings
presented in Figure 2 reﬂect additional adjustment of these
models for the absolute volume of VAT. In these models, the
presence of high TAT was associated with prevalent CVD in
both sexes (age- and VAT-adjusted P=0.01 in women,
Figure 2A; and P=0.004 in men, Figure 2B). In addition, among
women with normal VAT, high TAT was associated with
signiﬁcantly lower HDL levels (P=0.005) (Figure 2A). In men
withhighTATandnormalVAT,therewasahigherprevalenceof
smoking (age-VAT-adjusted P=0.02) and higher BMI (P=0.004)
compared with individuals with normal VAT and normal TAT.
After adjustment for the volume of VAT, the difference in the
prevalence of metabolic syndrome was no longer different
between those with high TAT versus normal TAT. When we
reexamined theassociation ofhigh TAT versus normalTAT with
CVD prevalence after adjustment for low HDL and current
smoking (in addition to adjustment for age and volume of VAT),
there remained a signiﬁcant association in both women
(P=0.02) and men (P=0.01).
There were multiple signiﬁcant age interactions across the
4 categories of TAT/VAT categories. Thus, we performed
analysis stratiﬁed by median age. The results were generally
similar to the overall ﬁndings (data not shown). Finally, in our
sensitivity analysis limited to the Third Generation cohort, who
underwent risk factor and MDCT assessment during the same
time period, ﬁndings were overall similar (Table 6).
Table 1. Clinical Characteristics of the Overall Sample*
Characteristic
Overall
(N=3246)
Women
(n=1558)
Men
(n=1688)
Age, y 51.110.4 52.39.9 49.910.7
BMI (kg/m
2) 27.75.2 27.05.8 28.44.5
Waist
circumference
(cm)
97.114.2 93.015.5 100.811.7
Low HDL
cholesterol
† (%)
29 26 33
Elevated
triglycerides
‡
(%)
36 27 44
Smoking status (%)
Current 13 12 13
Former 39 43 37
Never 48 45 50
Alcohol use
§ (%) 15 15 16
Physical
activity
index
37.67.2 36.75.8 38.38.2
Postmenopausal
(%)
— 51 —
Hypertension (%) 29 27 32
Impaired fasting
glucose
|| (%)
29 19 38
Diabetes (%) 7 6 7
Metabolic
syndrome (%)
33 27 38
CVD (%) 6 4 8
Hypertension
treatment (%)
19 19 20
Lipid treatment (%) 14 10 18
TAT (cm
3) 13.88.2 9.95.3 17.58.7
VAT (cm
3) 1818.71034.2 1356.7825.3 2243.21025.0
Data are presented as meanSD for continuous or % for categorical characteristics.
BMI indicates body mass index; HDL, high-density lipoprotein; CVD, cardiovascular
disease; TAT, thoracic periaortic fat; VAT, visceral adipose tissue.
*Sample sizes vary from row to row, as available data were used for a given characteristic.
†Deﬁned as <40 mg/dL (men) and <50 mg/dL (women).
‡Deﬁned as ≥150 mg/dL or lipid treatment.
§Deﬁned as ≥14 drinks weekly for men and ≥7 drinks weekly for women.
||Deﬁned as fasting plasma glucose 100 to 125 mg/dL and not currently taking diabetes
medication.
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HDiscussion
In our community-based sample, more than a third of
individuals had high TAT. In the absence of high VAT, excess
TAT identiﬁed a subset of individuals with a higher prevalence
of adverse cardiometabolic characteristics compared with
individuals without high TAT even after adjustment for total
volume of VAT. This included a higher prevalence of CVD in
both women and men, lower HDL levels in women, and a
higher prevalence of current smoking in men. These ﬁndings
provide a better understanding of the risk factor correlates of
TAT, a speciﬁc subtype of perivascular fat. Further experi-
mental studies are required to elucidate whether TAT is
pathogenic.
Multiple basic science and small clinical studies have
suggested a local effect of perivascular fat that changes
with the development of obesity.
5,6,8 Previous work in the
Table 2. Thoracic Periaortic Fat Percentiles Within Age Groups Among Women (n=1543) and Men (n=1634)*
Fat Volumes, cm
3
N 5th 10th 25th 50th 75th 90th >95th
Women (age), y
35 to 44 391 3.2 3.7 4.8 6.3 8.8 11.4 13.8
45 to 54 591 3.9 4.4 5.8 8.1 11.3 15.4 17.7
55 to 64 341 5.2 6.0 7.9 10.8 14.1 17.7 20.6
65 to 74 185 6.4 7.1 9.7 13.1 17.7 22.6 25.1
75 to 84 35 7 7.6 11.0 14.5 19.3 26.5 28.2
Men (age), y
35 to 44 559 5.9 6.7 9.5 12.5 16.9 22.0 26.8
45 to 54 582 7.2 8.9 11.7 15.2 20.1 25.2 29.5
55 to 64 280 9.8 11.7 15.1 20.2 26.3 31.8 38.7
65 to 74 182 11.1 12.6 17.5 23.6 31.7 39.6 43.9
75 to 84 31 7.9 13.2 16.2 23.1 34.5 42.7 43.9
*Fifteen women and 54 men from the total sample were either <35 years of age or missing information on age and therefore were excluded from this analysis.
Table 3. Sex-Speciﬁc Prevalence (Standard Error) of Excess
TAT* by Age Group
Women (n=1543)
† Men (n=1634)
†
Overall 38.1% (1.24) 35.7% (1.19)
35 to 44 15.3% (1.82) 17.9% (1.62)
45 to 54 32.7% (1.93) 29.4% (1.89)
55 to 64 52.8% (2.70) 57.5% (2.95)
65 to 74 69.2% (3.39) 72.0% (3.33)
75 to 84 77.1% (7.10) 67.7% (8.40)
P value for linear trend <0.0001 <0.0001
TAT indicates thoracic periaortic fat.
*Excess TAT deﬁned as ≥90 percentile of the sex-speciﬁc cut points (≥10.2 and
≥19.0 cm
3 in women and men, respectively) in a healthy referent sample.
†Fifteen women and 54 men from the total sample were either <35 years of age or
missing information on age and therefore were excluded from this analysis.
Table 4. Sex-Speciﬁc Prevalence (Standard Error) of High TAT* by BMI and Waist Circumference Category
BMI Category Women (n=1544) Men (n=1674) Waist Circumference Category Women (n=1539) Men (n=1671)
Normal weight
(BMI<25 kg/m
2)
12.4% (1.26) 6.6% (1.30) Normal waist circumference
(≤88 cm in women,
≤102 cm in men)
9.8% (1.16) 16.2% (1.18)
Overweight
(25 kg/m
2≤BMI<30 kg/m
2)
43.7% (2.28) 29.7% (1.59) High waist circumference
(>88 cm in women,
>102 cm in men)
58.5% (1.66) 60.8% (1.85)
Obese
(BMI≥30 kg/m
2)
75.4% (2.18) 65.0% (2.17)
TAT indicates thoracic periaortic fat; BMI, body mass index.
*High TAT deﬁned as ≥90 percentile sex-speciﬁc cut points (≥10.2 and ≥19.0 cm
3 in women and men, respectively) for TAT in a healthy referent sample.
DOI: 10.1161/JAHA.112.004200 Journal of the American Heart Association 5
Thoracic Periaortic Fat and Risk Factors Britton et al
O
R
I
G
I
N
A
L
R
E
S
E
A
R
C
HTable 5. Age-Adjusted Sex-Speciﬁc Distribution of Risk Factors and Clinical Characteristics by VAT/TAT Categories* Among
Women (n=1546) and Men (n=1682)
†
Risk Factor
Normal VAT/
Normal TAT
(A)
High VAT/
Normal TAT
(B)
High TAT/
Normal VAT
(C)
High VAT/
High TAT
(D)
Age-Adjusted P Value
Comparing Groups B and C
Women
n 787 168 86 505
Age (y) 48.7 51.6 57.3 57.2 <0.0001
BMI (kg/m
2) 23.4 29.2 26.2 32.1 <0.0001
Waist circumference (cm) 83.4 99.6 89.8 106.6 <0.0001
VAT (cm
3) 750.5 1693.6 1082 2236.4 <0.0001
TAT (cm
3) 6.5 8.6 12.1 15.1 <0.0001
Diabetes (%) 2.6 5.8 4.0 8.8 0.50
Impaired fasting glucose
‡ (%) 8.6 24.2 12.8 32.7 0.03
Hypertension (%) 16.6 31.7 21.1 39.5 0.049
Elevated triglycerides
§ (%) 12.8 34.9 28.3 44.1 0.27
Low HDL cholesterol
|| (%) 12.3 35.0 27.7 44.7 0.25
Metabolic syndrome (%) 5.9 38.0 17.4 55.6 0.0006
CVD (%) 1.5 4.0 7.5 6.2 0.20
Smoking status (%)
Current 9.9 12.3 17.4 16.7 0.29
Former 42.2 37.0 41.9 45.4 0.44
Never 48.2 50.8 41.1 38.7 0.15
Men
n 876 216 101 489
Age (y) 46 49.4 55.4 56.0 <0.0001
BMI (kg/m
2) 25.9 29.6 29.0 32.3 0.17
Waist circumference (cm) 94.2 104.7 102.0 110.6 0.017
VAT (cm
3) 1525.4 2788.6 1994.5 3340.6 <0.0001
TAT (cm
3) 12.2 15.4 22.4 26.6 <0.0001
Diabetes (%) 3.7 9.0 7.0 11.4 0.53
Impaired fasting glucose
‡ (%) 29.7 40.3 39.8 49.5 0.92
Hypertension, % 22.5 33.0 35.7 45.4 0.62
Elevated triglycerides
§ (%) 31.1 57.3 56.2 57.7 0.85
Low HDL cholesterol
|| (%) 22.5 41.7 40.2 46.2 0.80
Metabolic syndrome (%) 17.0 51.8 45.7 66.9 0.32
CVD (%) 4.6 8.5 11.7 9.6 0.32
Smoking status (%)
Current 11.3 14.0 18.6 16.3 0.31
Former 33.1 35.5 38.8 42.1 0.55
Never 55.5 50.9 43.0 41.4 0.19
VAT indicates visceral adipose tissue; TAT, thoracic periaortic fat; BMI, body mass index; HDL, high-density lipoprotein; CVD, cardiovascular disease.
*TAT and VAT categories are deﬁned as high if ≥90th percentile sex-speciﬁc cut points in healthy referent sample. High TAT corresponded to volumes ≥10.2 and ≥19.0 cm
3 in women and
men, respectively. High VAT has been previously deﬁned as ≥1359 cm
3 in women and ≥2323 cm
3 in men.
†Sample sizes vary from row to row, as available data were used for a given characteristic.
‡Deﬁned as fasting plasma glucose 100 to 125 mg/dL and not currently taking diabetes medication.
§Deﬁned as ≥150 mg/dL or lipid treatment.
||Deﬁned as <40 mg/dL (men) and <50 mg/dL (women).
DOI: 10.1161/JAHA.112.004200 Journal of the American Heart Association 6
Thoracic Periaortic Fat and Risk Factors Britton et al
O
R
I
G
I
N
A
L
R
E
S
E
A
R
C
HFramingham Heart Study has demonstrated a novel and
reliable method of quantifying thoracic periaortic fat by
MDCT.
9 We now present a comprehensive age- and sex-
speciﬁc description of TAT distribution in a community-based
sample and report differences in cardiometabolic features
among subcategories of TAT and VAT.
Our ﬁndings that more than one third of individuals in the
community had high TAT is similar to our previous reports of
fat depots, including VAT, pericardial, and intrathoracic
fat.
18,19 Despite this similar prevalence among various fat
depots, our ﬁndings suggest that a high volume of TAT is
associated with adverse cardiometabolic features among the
subset of individuals with normal VAT. Prior work has
highlighted the existence of “metabolically obese normal
weight individuals” who exhibit glucose intolerance and
hyperinsulinemia despite a normal BMI.
20 Differences in
visceral adiposity have been postulated to contribute to this
phenotype.
21 Our ﬁndings suggest that high thoracic periaor-
tic fat may also identify a “metabolically obese” group among
individuals who do not meet criteria for excess VAT. Some of
these differences, such as the higher prevalence of CVD, are
present in both sexes. However, others are sex speciﬁc, with a
prevalence of low HDL higher in women than men. This ﬁnding
is consistent with prior literature suggesting stronger asso-
ciations of ectopic fat and metabolic risk factors in women
compared with men. However, the prevalence of current
smoking was higher in men than in women with high TAT/
normal VAT compared with normal TAT/normal VAT.
TAT is directly wrapped around the aorta, and this distinct
anatomic location may explain the speciﬁc association
between high TAT and CVD among individuals with normal
VAT. TAT may serve as a marker of perivascular fat
throughout the body including smaller blood vessels, and
perivascular fat has been postulated to have adverse effects
on the vasculature.
4,5 Supporting this, prior work in the
Framingham Heart Study has demonstrated an association
between TAT and both abdominal aortic calcium and coronary
artery calcium among individuals without known cardiovas-
cular disease. These associations persisted after adjustment
for VAT and standard cardiovascular risk factors.
10 Alterna-
tively, our ﬁndings that high TAT was associated with CVD
among individuals with normal VAT may reﬂect that these
individuals were more likely to have a higher prevalence of
certain CVD risk factors, including low HDL in women and
smoking in men.
Our ﬁndings of a difference in the prevalence of smoking
among men with normal VAT but discordant for TAT deserves
speciﬁc comment. Smokers tend to have a lower body weight
but are known to have a higher risk of cardiovascular
disease. Ectopic fat distribution, speciﬁcally higher volumes
of VAT, is already known to differ between smokers and
nonsmokers.
22 We have extended these ﬁndings among
individuals with normal VAT by demonstrating a higher
prevalence of male smokers among individuals with high
versus normal TAT. These ﬁndings are noteworthy given the
potential modulating role of nicotine on perivascular fat
previously demonstrated in animal models.
23 Speciﬁcally,
exposure of rats to nicotine prenatally and during lactation
led to an increase in total adiposity as well as perivascular fat
in the offspring compared with controls. Furthermore, the
normal anticontractile effect of perivascular fat on blood
vessels was no longer present in nicotine-exposed offspring,
but was restored with the transfer of the medium surround-
ing normal fat. Thus, nicotine was associated with higher
volumes as well as dysfunction of perivascular fat. These
ﬁndings are consistent with prior work suggesting that
excess perivascular adipose tissue disrupts the normal
contribution of perivascular fat to vascular tone
24 and further
suggest that nicotine may contribute to this process. Other
studies also support a potential role of nicotine on adipose
tissue.
25,26 For example, differences in adipose tissue
lipoprotein lipase activity have been found between smokers
and nonsmokers.
25 Thus, elucidation of the full expression
proﬁle of perivascular fat in response to nicotine may help to
extend our observational ﬁndings.
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Figure 2. Differences in cardiometabolic features among (A)
women (n=873) and (B) men (n=977) with normal VAT/normal TAT
vs normal VAT/high TAT. Prevalence rates and P values are adjusted
for age and volume of VAT. CVD indicates cardiovascular disease;
HDL, high-density lipoprotein; TAT, thoracic periaortic adipose tissue;
VAT, visceral adipose tissue.
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Women (n=848) and Men (n=1038) Limited to the Third Generation
†
Risk Factor
Normal VAT/
Normal TAT
(A)
High VAT/
Normal TAT
(B)
High TAT/
Normal VAT
(C)
High VAT/
High TAT
(D)
Age-Adjusted P Value
Comparing Groups B and C
Women
n 518 54 66 210
Age (y) 45.3 46.2 47 48.2 0.40
BMI (kg/m
2) 23.4 30.2 26.3 33.2 <.0001
Waist circumference (cm) 82.3 99.8 90.9 108.2 <.0001
VAT (cm
3) 688.8 1653.8 1037.9 2125 <.0001
TAT (cm
3) 5.7 7.5 10.2 13.1 <.0001
Diabetes (%) 1.5 5.6 1.4 6.1 0.21
Impaired fasting glucose
‡ (%) 5.9 24.1 10.2 30.4 0.04
Hypertension (%) 10.0 25.9 15.2 31.1 0.13
Elevated triglycerides
§ (%) 6.6 22.2 25.1 39.1 0.71
Low HDL cholesterol
|| (%) 14.5 38.9 24.7 47.3 0.10
Metabolic syndrome (%) 2.8 28.2 14.5 52.3 0.06
CVD (%) 0.2 1.9 0.0 3.0 0.95
Smoking status
Current 11.7 16.7 15.8 19.9 0.90
Former 36.6 27.8 41.6 36.2 0.12
Never 51.9 55.6 42.5 44.4 0.16
Men
N 585 85 130 238
Age (y) 42.5 44.4 45.5 46.4 0.22
BMI (kg/m
2) 25.9 30 28.1 32.7 0.0001
Waist circumference (cm) 93.3 104.7 100.4 111.5 0.0007
VAT (cm
3) 1424.7 2744.4 1940.7 3094.9 <.0001
TAT (cm
3) 10.5 13.5 18.7 23.2 <.0001
Diabetes (%) 2.5 9.3 1.3 8.1 0.01
Impaired fasting glucose
‡ (%) 25.6 40.2 41.4 46.5 0.86
Hypertension (%) 15.1 35.8 26.7 40.4 0.145
Elevated triglycerides
§ (%) 26.9 62.1 53.1 58.1 0.19
Low HDL Cholesterol
|| (%) 20.2 54.5 35.7 42.5 0.01
Metabolic syndrome (%) 12.9 59.7 37.5 67.3 0.002
CVD (%) 2.2 4.6 0.7 3.1 0.08
Smoking status (%)
Current 12.8 8.3 18.8 21.2 0.04
Former 23.9 27.3 27.3 28.6 0.99
Never 63.3 64.3 54.1 50.2 0.13
VAT indicates visceral adipose tissue; TAT, thoracic periaortic fat; BMI indicates body mass index; CVD, cardiovascular disease; HDL, high-density lipoprotein.
*TAT and VAT categories are deﬁned as high if ≥90th percentile sex-speciﬁc cut points in healthy referent sample. In the Third Generation, high TAT corresponded to volumes ≥8.79 and
15.72 cm
3 in women and men, respectively. High VAT has been previously deﬁned as ≥1359 cm
3 in women and ≥2323 cm
3 in men.
†Sample sizes vary from row to row, as available data were used for a given characteristic.
‡Deﬁned as fasting plasma glucose 100 to 125 mg/dL and not currently taking diabetes medication.
§Deﬁned as ≥150 mg/dL or lipid treatment.
||Deﬁned as <40 mg/dL (men) and <50 mg/dL (women).
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The major strength of our study is the relatively large sample
size and community-based nature of the cohort. This allowed
exploration of differences within subgroups of TAT and VAT
and limited referral bias. We assessed TAT and VAT using a
highly reproducible CT volumetric assessment. Certain
limitations warrant discussion. The cross-sectional and
observational design of the analysis prevents inferences of
causality or temporality. The Framingham Heart Study is
predominantly white, and results cannot be generalized to
other ethnic groups. We did not have information on the
severity of CVD. Our analyses were exploratory, and we did
not account for multiple testing. Replication of our ﬁndings in
independent cohorts is warranted. There were temporal
differences between the MDCT scans and the risk factor
assessments among the Offspring cohort. However, our
sensitivity analysis limited to the Third-Generation cohort (in
which MDCT scans and risk factor assessment occurred
during the same period) demonstrated overall similar ﬁndings.
Finally, our ﬁndings do not suggest that TAT quantiﬁcation
should be used as a clinical tool.
Conclusions
Elevated TAT is prevalent in the community and is associated
with adverse cardiometabolic features, including CVD, smok-
ing, and low HDL among individuals with normal VAT. Further
work to better understand the biology of TAT and its
association with metabolic and cardiovascular disease may
provide insight into a potentially unique pathogenic role of
periaortic fat.
Sources of Funding
ThisworkwassupportedbytheNationalHeart,Lung,andBlood
Institute’s Framingham Heart Study (contract N01-HC-25195).
Dr. Britton was supported by a Research Career Development
Award (K12 HL083786) from the National Heart, Lung, and
Blood Institute.
Disclosures
Alison Pedley is an employee of Merck & Company. The
remaining authors report no conﬂicts.
References
1. Poirier P, Giles TD, Bray GA, Hong Y, Stern JS, Pi-Sunyer FX, Eckel RH. Obesity
and cardiovascular disease: pathophysiology, evaluation, and effect of weight
loss: an update of the 1997 American Heart Association Scientiﬁc Statement
on Obesity and Heart Disease from the Obesity Committee of the Council on
Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113:898–918.
2. Canoy D, Boekholdt SM, Wareham N, Luben R, Welch A, Bingham S, Buchan I,
Day N, Khaw K-T. Body fat distribution and risk of coronary heart disease in
men and women in the European Prospective Investigation into Cancer and
Nutrition in Norfolk cohort: a population-based prospective study. Circulation.
2007;116:2933–2943.
3. Montani JP, Carroll JF, Dwyer TM, Antic V, Yang Z, Dulloo AG. Ectopic fat
storage in heart, blood vessels and kidneys in the pathogenesis of
cardiovascular diseases. Int J Obes Relat Metab Disord. 2004;28:S58–
S65.
4. Yudkin JS, Eringa E, Stehouwer CDA. “Vasocrine” signalling from perivascular
fat: a mechanism linking insulin resistance to vascular disease. Lancet.
2005;365:1817–1820.
5. Greenstein AS, Khavandi K, Withers SB, Sonoyama K, Clancy O, Jeziorska M,
Laing I, Yates AP, Pemberton PW, Malik RA, Heagerty AM. Local inﬂammation
and hypoxia abolish the protective anticontractile properties of perivascular fat
in obese patients. Circulation. 2009;119:1661–1670.
6. Soltis E, Cassis L. Inﬂuence of perivascular adipose tissue on rat aortic smooth
muscle responsiveness. Clin Exp Hypertens A. 1991;13:277–296.
7. Eringa EC, Bakker W, Smulders YM, Sern e EH, Yudkin JS, Stehouwer CDA.
Regulation of vascular function and insulin sensitivity by adipose tis-
sue: focus on perivascular adipose tissue. Microcirculation. 2007;14:
389–402.
8. Chatterjee TK, Stoll LL, Denning GM, Harrelson A, Blomkalns AL, Idelman G,
Rothenberg FG, Neltner B, Romig-Martin SA, Dickson EW, Rudich S, Weintraub
NL. Proinﬂammatory phenotype of perivascular adipocytes: inﬂuence of high-
fat feeding. Circ Res. 2009;104:541–549.
9. Schlett CL, Massaro JM, Lehman SJ, Bamberg F, O’Donnell CJ, Fox CS,
Hoffmann U. Novel measurements of periaortic adipose tissue in comparison
to anthropometric measures of obesity, and abdominal adipose tissue. Int J
Obes. 2009;33:226–232.
10. Fox CS, Massaro JM, Schlett CL, Lehman SJ, Meigs JB, O’Donnell CJ, Hoffmann
U, Murabito JM. Peri-aortic fat deposition is associated with peripheral arterial
disease: the Framingham Heart Study. Circ Cardiovasc Imaging. 2010;3:515–
519.
11. Lehman SJ, Massaro JM, Schlett CL, O’Donnell CJ, Hoffmann U, Fox CS. Peri-
aortic fat, cardiovascular disease risk factors, and aortic calciﬁcation: the
Framingham Heart Study. Atherosclerosis. 2010;210:656–661.
12. Fox CS, Massaro JM, Hoffmann U, Pou KM, Maurovich-Horvat P, Liu C-Y, Vasan
RS, Murabito JM, Meigs JB, Cupples LA, D’Agostino RB Sr, O’Donnell CJ.
Abdominal visceral and subcutaneous adipose tissue compartments: associ-
ation with metabolic risk factors in the Framingham Heart Study. Circulation.
2007;116:39–48.
13. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An
investigation of coronary heart disease in families. Am J Epidemiol. 1979;110:
281–290.
14. Splansky GL, Corey D, Yang Q, Atwood LD, Cupples LA, Benjamin EJ,
D’Agostino RB, Fox CS, Larson MG, Murabito JM, O’Donnell CJ, Vasan RS, Wolf
PA, Levy D. The third generation cohort of the national heart, lung, and blood
institute’s Framingham Heart Study: design, recruitment, and initial examina-
tion. Am J Epidemiol. 2007;165:1328–1335.
15. Maurovich-Horvat P, Massaro J, Fox CS, Moselewski F, O’Donnell CJ,
Hoffmann U. Comparison of anthropometric, area- and volume-based
assessment of abdominal subcutaneous and visceral adipose tissue
volumes using multi-detector computed tomography. Int J Obes. 2006;31:
500–506.
16. Kannel WB, Sorlie P. Some health beneﬁts of physical activity: the Framingham
Study. Arch Intern Med. 1979;139:857–861.
17. Expert Panel on Detection, Evaluation, and Treatment of High Blood
Cholesterol in Adults. Executive summary of the third report of the national
cholesterol education program (NCEP) expert panel on detection, evaluation,
and treatment of high blood cholesterol in adults (adult treatment panel III).
JAMA. 2001;285:2486–2497.
18. Pou KM, Massaro JM, Hoffmann U, Lieb K, Vasan RS, O’Donnell CJ, Fox
CS. Patterns of abdominal fat distribution. Diabetes Care. 2009;32:481–
485.
19. Thanassoulis G, Massaro JM, Hoffmann U, Mahabadi AA, Vasan RS,
O’Donnell CJ, Fox CS. Prevalence, distribution, and risk factor correlates
of high pericardial and intrathoracic fat depots in the Framingham
Heart Study/clinical perspective. Circ Cardiovasc Imaging. 2010;3:559–
566.
20. Ruderman NB, Schneider SH, Berchtold P. The “Metabolically-obese”, normal-
weight individual. Am J Clin Nutr. 1981;34:1617–1621.
21. Ruderman N, Chisholm D, Pi-Sunyer X, Schneider S. The metabolically obese,
normal-weight individual revisited. Diabetes. 1998;47:699–713.
DOI: 10.1161/JAHA.112.004200 Journal of the American Heart Association 9
Thoracic Periaortic Fat and Risk Factors Britton et al
O
R
I
G
I
N
A
L
R
E
S
E
A
R
C
H22. Molenaar EA, Massaro JM, Jacques PF, Pou KM, Ellison RC, Hoffmann U,
Pencina K, Shadwick SD, Vasan RS, O’Donnell CJ, Fox CS. Association of
lifestyle factors with abdominal subcutaneous and visceral adiposity. Diabetes
Care. 2009;32:505–510.
23. Gao Y-J, Holloway AC, Z-H ZENG, Lim GE, Petrik JJ, Foster WG, Lee RMKW.
Prenatal exposure to nicotine causes postnatal obesity and altered perivas-
cular adipose tissue function. Obesity. 2005;13:687–692.
24. Lohn M, Dubrovska G, Lauterbach B, Luft FC, Gollasch M, Sharma AM.
Periadventitialfatreleasesavascularrelaxingfactor.FASEBJ.2002;16:1057–1063.
25. Brunzell J, Goldberg A, Schwartz R. Cigarette smoking and adipose tissue
lipoprotein lipase. Int J Obes. 1980;4:101–103.
26. Andersson K, Arner P. Systemic nicotine stimulates human adipose tissue
lipolysis through local cholinergic and catecholaminergic receptors. Int J Obes
Relat Metab Disord. 2001;25:1225–1232.
DOI: 10.1161/JAHA.112.004200 Journal of the American Heart Association 10
Thoracic Periaortic Fat and Risk Factors Britton et al
O
R
I
G
I
N
A
L
R
E
S
E
A
R
C
H